Generic competition · all medicines · read 12 November 2026
Is there a generic of Ibuprofen, and who makes it?
Ibuprofen appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 32 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 0.9 and 9.2 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Ibuprofen appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 32 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 0.9 and 9.2 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Four or more generic makers listed
Brand listed as marketed: Advil, Junior Strength Advil, Junior Strength Motrin and Motrin Ib. 15 generic makers with 56 generic products listed as marketed; the first generic approval is dated 8 February 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Contract Pharmacal Corp | 15 October 1986 | 4 |
| Amneal Pharmaceuticals Ny Llc | 25 November 1986 | 7 |
| L Perrigo Co | 8 December 1987 | 1 |
| Mcneil Consumer Products Co Div Mcneilab Inc | 30 March 1994 | 1 |
| Lnk International Inc | 1 March 1999 | 2 |
| Dr Reddys Laboratories Inc | 31 October 2001 | 8 |
| Avema Pharma Solutions | 26 November 2003 | 1 |
| Perrigo R And D Co | 21 June 2005 | 1 |
| Strides Pharma Global Pte Ltd | 5 February 2009 | 5 |
| Granules India Ltd | 10 December 2010 | 5 |
| Pharmazone | 21 December 2010 | 5 |
| Shandong Xinhua Pharmaceutical Co Ltd | 23 November 2016 | 6 |
3 more makers are listed in the data.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Suspension, Oral
Four or more generic makers listed
Brand listed as marketed: Children's Advil, Children's Advil-Flavored, Children's Motrin and Motrin Ib. 11 generic makers with 14 generic products listed as marketed; the first generic approval is dated 25 March 1998.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Actavis Mid Atlantic Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc | 25 March 1998 | 1 |
| L Perrigo Co | 22 December 1998 | 1 |
| P And L Development Llc | 30 April 1999 | 1 |
| Padagis Us Llc | 23 September 2004 | 1 |
| Sun Pharma Canada Inc | 23 June 2017 | 2 |
| Aurobindo Pharma Ltd | 16 February 2018 | 2 |
| Guardian Drug Co | 17 August 2018 | 1 |
| Annora Pharma Private Ltd | 23 November 2018 | 1 |
| Strides Pharma Global Pte Ltd | 22 February 2021 | 2 |
| Pai Holdings Llc Dba Pharmaceutical Associates Inc | 8 November 2024 | 1 |
| Rubicon Research Ltd | 5 March 2026 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Capsule, Oral
Four or more generic makers listed
Brand listed as marketed: Advil Liqui-Gels, Advil Migraine Liqui-Gels and Midol Liquid Gels. 10 generic makers with 11 generic products listed as marketed; the first generic approval is dated 2 September 1987.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Bionpharma Inc | 24 March 2009 | 1 |
| Pharmazone | 26 June 2009 | 1 |
| P And L Development Llc Dba Pld Developments Llc | 10 July 2009 | 1 |
| Amneal Pharmaceuticals Of New York Llc | 23 December 2011 | 1 |
| Humanwell Puracap Pharmaceutical Wuhan Co Ltd | 21 June 2016 | 1 |
| Sofgen Pharmaceuticals Llc | 7 September 2016 | 1 |
| Ascent Pharmaceuticals Inc | 21 December 2017 | 1 |
| Onesource Softgels Pte Ltd | 28 March 2018 | 1 |
| Aurobindo Pharma Ltd | 29 June 2018 | 2 |
| Patheon Softgels Bv | 13 February 2024 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Suspension/Drops, Oral
Four or more generic makers listed
Brand listed as marketed: Children's Motrin and Infant's Advil. 5 generic makers with 5 generic products listed as marketed; the first generic approval is dated 16 December 1998.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| L Perrigo Co | 16 December 1998 | 1 |
| Tris Pharma Inc | 31 August 2009 | 1 |
| Guardian Drug Co | 26 September 2018 | 1 |
| Sun Pharma Canada Inc | 8 August 2023 | 1 |
| Aurobindo Pharma Ltd | 8 April 2024 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Tablet, Chewable, Oral
One to three generic makers listed
Brand listed as marketed: Children's Advil and Junior Strength Advil. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 16 January 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| L Perrigo Co | 16 January 2004 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Intravenous
Brand listed, no generic listed as marketed
Brand listed as marketed: Caldolor. No generic is listed as marketed.
Patents and exclusivities still listed
- 30 September 2029Patent 9114068
- 30 September 2029Patent 8735452
- 30 September 2029Patent 9649284
- 30 September 2029Patent 8871810
- 30 September 2029Patent 9295639
- 30 September 2029Patent 9138404
- 14 September 2030Patent 9012508
- 16 March 2032Patent 11806400
2 more patents are listed.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.